-
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
28 Mar 2024 12:00 GMT
… , we seek to develop drugs that are effective against … FDA on a Pre-IND package improving clarity on clinical trial … CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique … changes, and potential development of effective treatments and/or …
-
Are new treatments for multiple sclerosis on the horizon?
27 Mar 2024 18:35 GMT
… tackle virus infections like hepatitis C virus infections, SARS … difficult.
These drugs act as immunomodulatory drugs and … BTK inhibitor clinical trials
French biopharma Sanofi’s … develop.
BTK inhibitors’ promise in multiple sclerosis treatment
However …
-
Preventing Mother-to-Child Transmission of Hepatitis C
25 Mar 2024 16:56 GMT
… sofosbuvir (SOF), a medication in HCV treatment, were 38% higher …
In this phase 1 trial, HIV-negative pregnant women … studies. An international multicenter trial (NCT05140941) is underway to … in Pregnant Women With Hepatitis C Virus. Poster #710 …
-
Insights from patient who cleared hepatitis C could lead to vaccine
25 Mar 2024 14:27 GMT
… hepatitis C virus clear the infection on their own without treatment, … drugs.
Antibodies from an individual who cleared multiple Hepatitis C … a big interest in developing a hepatitis C vaccine,” said Andrew … bring into human clinical trials.
Clinton Ogega, a …
-
Immune Thrombocytopenia Market Report 2032: Epidemiology, Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight
27 Mar 2024 12:56 GMT
… erythematosus (SLE), certain medications, Hepatitis C, human immunodeficiency virus … Drugs Uptake and Pipeline Development Activities
The drugs … prospective trials could refine treatment strategies and … of pipeline treatments are in development for managing …
-
Atea Pharmaceuticals Completes Patient Enrollment in Global Phase 3 SUNRISE-3 Trial Evaluating Oral Antiviral Bemnifosbuvir for COVID-19 in High-Risk Patients
27 Mar 2024 11:00 GMT
… includes other compatible antiviral drugs against COVID-19 (secondary … in the trial through Day 60 post-treatment. In March … company focused on discovering, developing and commercializing oral antiviral … causes COVID-19, and hepatitis C virus (HCV). For more …
-
Women Making History: UK researcher works to reduce harms from substance use
29 Mar 2024 13:55 GMT
… Kentucky researcher has been developing new methods to help … harms such as overdose and hepatitis C. One such project is … hurdles often include transportation to treatment, being refused prescriptions, … recruit people who use drugs by doing everything from …
-
Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight
25 Mar 2024 17:00 GMT
… viral medications to treat hepatitis C) helps … prevent cirrhosis from worsening.
Find out more about cirrhosis treatment drugs @ Drugs … Cirrhosis Clinical Trials Cirrhosis Therapeutics … Cour Pharmaceutical Development, Ascletis, Novartis …
-
Revolutionizing Treatment Strategies for Autoimmune and Inflammatory Disorders: The Impact of Dipeptidyl-Peptidase 4 Inhibitors
23 Mar 2024 05:15 GMT
… of oral hypoglycemic medications for the treatment of T2DM is … as IP-10) in chronic hepatitis C virus (HCV) patients, … aid in the development of new drugs that target specific … double‐blind, randomized, crossover trial. Diabetic Med. 2011;28:1176–1181. …
-
For Canada to ensure a prosperous future, doubling down on research is essential
27 Mar 2024 19:51 GMT
… . Additionally researchers are creating cures, treatments and vaccines that will enable … he has developed for Hepatitis C, we would save the current treatment costs that …